MMIT - Managed Markets Insight & Technology

24/12/2025

"[MMIT's new platform] lets us manipulate the initial landing page to see what we're most interested in as an organization. We can look at competitive coverage and restrictions side by side for any class, which is really nice. Then we can narrow it down as much as we want to a specific status or step."

- Director of National Accounts
Midsize Biopharmaceutical Company

Learn more about The MMIT Platform: https://vist.ly/4jmbn

MMIT’s Platform is a strategic leap forward—built to streamline how commercialization teams access insights, execute workflows, and make decisions.

23/12/2025

Use Case Download: Here's how MMIT, with NorstellaLinQ, integrated unstructured EMR data with structured data to help a global pharma company pinpoint rare disease screening patterns and inform commercialization strategies. https://vist.ly/4jjz6

23/12/2025

https://vist.ly/4jjdx | You can’t make confident access decisions without complete data. MMIT Analytics provides the most comprehensive view of formulary coverage, medical policies, and restriction information. Use it to evaluate patient access for your brand and your competitors. Sharper insights lead to better decisions. Learn more at the link in this post.

23/12/2025

https://vist.ly/4jht9 | Looking to unlock the right payer insights for your team? MMIT’s Payer Landscape and Directory of Health Plans deliver powerful data to guide smarter market access strategies, but which one is the best fit for your goals? Our new infographic makes it easy to compare both solutions side by side. Download now and choose your path to more informed decisions.

21/12/2025

Free-text data is messy — and it’s holding your access strategy back.
Conflicting plan names, duplicate entries, and poor match rates create unnecessary barriers.

MMIT’s BIN/PCN/Group patient data bridges these gaps by connecting curated, real-world data to the industry’s most reliable plan structure.

✅ No client data required
✅ Rapid benefit connection
✅ Combined with Norstella’s real-world insights for unmatched value
Make faster, smarter market access decisions.

Connect with MMIT today. https://vist.ly/4jcds

For decades, the industry has tried to identify patients’ health plans using messy free-text fields. Today, BIN, PCN, and Group ID offer a more accurate way forward.

21/12/2025

WATCH: Access to real-world data is just the beginning. To make a real impact, that data needs to work for you. MMIT, powered by NorstellaLinQ, delivers insights when and how you need them—through cloud, files, or dashboards. That means your team can stay focused on strategy, rather than being stuck managing vendors or wrangling data. Watch this video to see how we help biopharma teams turn data into decisions: https://vist.ly/4jbzb

20/12/2025

https://vist.ly/4javw | Unstructured data holds untapped value. We make it usable. MMIT and its parent company, Norstella, convert clinical notes and EMR narratives into structured, connected insights. The result is a clearer view of the patient journey and the ability to act on it. See how we do it.

20/12/2025

Use Case Download: Discover how MMIT, powered by NorstellaLinQ, is redefining rare disease targeting through real-world data. https://vist.ly/4ja5c

20/12/2025

How is your team understanding the intricacies of the patient experience? Where are you gaining the “connective tissue” that links payer decisions and patient outcomes?

Read our latest article to see how MMIT provides data not only to identify access barriers, but also their impact and how to overcome them without more significant delays.

Read now📚. https://vist.ly/4j9zt

Discover how real-world data reveals the impact of payer policy decisions on patient outcomes. Market access research coupled with insights from real-world data sources (claims, labs, and EMR data) helps pharma companies identify and mitigate access roadblocks.

19/12/2025

https://vist.ly/4j7qg | Get closer to the patient than ever before. MMIT, powered by NorstellaLinQ, delivers pharma’s first fully linked and integrated data asset. With unmatched access to open and closed claims, lab results, EMRs, and coverage data, we help you build smarter, faster market access strategies. Learn more at the link in this post.

19/12/2025

REAL-WORLD DATA CONTENT HUB: Rare doesn’t mean unreachable. Our exclusive content hub demonstrates how NorstellaLinQ—pharma’s first fully integrated real-world data asset—combines structured and unstructured data to identify previously hidden patient populations, expedite diagnoses, and enhance targeting strategies.

Explore expert insights, real-world use cases, and strategies that close the gaps traditional data sources miss. Start here: https://vist.ly/4j66d

18/12/2025

https://vist.ly/4i2ap | Get closer to the patient than ever before. MMIT, powered by NorstellaLinQ, delivers pharma’s first fully linked and integrated data asset. With unmatched access to open and closed claims, lab results, EMRs, and coverage data, we help you build smarter, faster market access strategies. Learn more at the link in this post.